The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
Abstract
We present here, the design, synthesis, spectroscopic characterization, and in vitro biological assessment of a gemcitabine-coumarin-biotin conjugate (5). Probe 5 is a multifunctional molecule composed of a thiol-specific cleavable disulfide bond, a coumarin moiety as a fluorescent reporter, gemcitabine (GMC) as a model active drug, and biotin as a cancer-targeting unit. Upon addition of free thiols that are relatively abundant in tumor cells, disulfide bond cleavage occurs as well as active drug GMC release and concomitantly fluorescence intensity increases. Confocal microscopic experiments reveal that 5 is preferentially taken up by A549 cells rather than WI38 cells. Fluorescence-based colocalization studies using lysosome- and endoplasmic reticulum-selective dyes suggest that thiol-induced disulfide cleavage of 5 occur in the lysosome possibly via receptor-mediated endocytosis. The present drug delivery system is a new theranostic agent, wherein both a therapeutic effect and drug uptake can be readily monitored at the subcellular level by two photon fluorescence imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Self-assembly of a nanoscale DNA box with a controllable lid
Andersen, E. S., Dong, M., Nielsen, M. M., Jahn, K., Subramani, R., Mamdouh, W., Golas, M. M., Sander, B., Stark, H., Oliveira, C. L. P., et al. (2009) · Nature · doi:10.1038/nature07971 · Cited by 1,627
Functionalized mesoporous silica materials for controlled drug delivery
Yang, P., Gai, S., & Lin, J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15308d · Cited by 1,399
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
A Fluorogenic 1,3-Dipolar Cycloaddition Reaction of 3-Azidocoumarins and Acetylenes
Sivakumar, K., Xie, F., Cash, B. M., Long, S., Barnhill, H. N., & Wang, Q. (2004) · Organic Letters · doi:10.1021/ol047955x · Cited by 699
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
Singh, N., Karambelkar, A., Gu, L., Lin, K., Miller, J. S., Chen, C. S., Sailor, M. J., & Bhatia, S. N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206998x · Cited by 363
Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S. S., & Ojima, I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005656 · Cited by 357
Heo, D. N., Yang, D. H., Moon, H.-J., Lee, J. B., Bae, M. S., Lee, S. C., Lee, W. J., Sun, I.-C., & Kwon, I. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.064 · Cited by 357
Self-citationThe Stability of N-Ethylmaleimide and its Reaction with Sulfhydryl Groups
Gregory, J. D. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01619a073 · Cited by 345
Lee, M. H., Kim, J. Y., Han, J. H., Bhuniya, S., Sessler, J. L., Kang, C., & Kim, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303998y · Cited by 309
Self-citationPreclinical characteristics of gemcitabine
Plunkett, W., Huang, P., & Gandhi, V. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199512006-00002 · Cited by 283
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs
Zhang, J., Visser, F., King, K. M., Baldwin, S. A., Young, J. D., & Cass, C. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9044-4 · Cited by 231
Polymeric micelles for oral drug delivery: Why and how
Francis, M. F., Cristea, M., & Winnik, F. M. (2004) · Pure and Applied Chemistry · doi:10.1351/pac200476071321 · Cited by 197
Understanding Ribonucleotide Reductase Inactivation by Gemcitabine
Cerqueira, N. M. F. S. A., Fernandes, P. A., & Ramos, M. J. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200700260 · Cited by 161
Carriers in the Topical Treatment of Skin Disease
Körting, H. C., & Schäfer‐Korting, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_15 · Cited by 132
Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors
Reid, J. M., Qu, W., Safgren, S. L., Ames, M. M., Krailo, M., Seibel, N. L., Kuttesch, J. F., & Holcenberg, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.142 · Cited by 106
Diversity-oriented syntheses of 7-substituted lentiginosines
Cordero, F. M., Bonanno, P., Chioccioli, M., Gratteri, P., Robina, I., Moreno‐Vargas, A. J., & Brandi, A. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.10.008 · Cited by 21
Jung, J., Solanki, A., Memoli, K. A., Kamei, K., Kim, H., Drahl, M. A., Williams, L. J., Tseng, H., & Lee, K. (2009) · Angewandte Chemie · doi:10.1002/ange.200905126 · Cited by 18
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Li, M., Xia, J., Tian, R., Wang, J., Fan, J., Du, J., Long, S., Song, X., Foley, J. W., & Peng, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08658 · Cited by 673
Wu, X., Sun, X., Guo, Z., Tang, J., Shen, Y., James, T. D., Tian, H., & Zhu, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412380j · Cited by 539
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Self-citation
Metadata
- Authors
- Maiti, S., Park, N., Han, J. H., Jeon, H. M., Lee, J. H., Bhuniya, S., Kang, C., & Kim, J. S.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-03-12
- Volume
- 135
- Issue
- 11
- Pages
- 4567-4572
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2043002859
- Cited by
- 327
- References
- 20
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.